125 related articles for article (PubMed ID: 38412677)
1. Irisin protects against cardiac injury by inhibiting NLRP3 inflammasome-mediated pyroptosis during remodeling after infarction.
Jin L; Piao Z
Int Immunopharmacol; 2024 Mar; 130():111714. PubMed ID: 38412677
[TBL] [Abstract][Full Text] [Related]
2. Piperazine ferulate protects against cardiac ischemia/reperfusion injury in rat via the suppression of NLRP3 inflammasome activation and pyroptosis.
Lei Z; Luan F; Zhang X; Peng L; Li B; Peng X; Liu Y; Liu R; Zeng N
Eur J Pharmacol; 2022 Apr; 920():174856. PubMed ID: 35219728
[TBL] [Abstract][Full Text] [Related]
3. Uric acid aggravates myocardial ischemia-reperfusion injury via ROS/NLRP3 pyroptosis pathway.
Shen S; He F; Cheng C; Xu B; Sheng J
Biomed Pharmacother; 2021 Jan; 133():110990. PubMed ID: 33232925
[TBL] [Abstract][Full Text] [Related]
4. Lipopolysaccharide (LPS) Aggravates High Glucose- and Hypoxia/Reoxygenation-Induced Injury through Activating ROS-Dependent NLRP3 Inflammasome-Mediated Pyroptosis in H9C2 Cardiomyocytes.
Qiu Z; He Y; Ming H; Lei S; Leng Y; Xia ZY
J Diabetes Res; 2019; 2019():8151836. PubMed ID: 30911553
[TBL] [Abstract][Full Text] [Related]
5. Qishen granule (QSG) exerts cardioprotective effects by inhibiting NLRP3 inflammasome and pyroptosis in myocardial infarction rats.
Chen X; Li Y; Li J; Liu T; Jiang Q; Hong Y; Wang Q; Li C; Guo D; Wang Y
J Ethnopharmacol; 2022 Mar; 285():114841. PubMed ID: 34793884
[TBL] [Abstract][Full Text] [Related]
6. Sacubitril/valsartan (LCZ696) reduces myocardial injury following myocardial infarction by inhibiting NLRP3‑induced pyroptosis via the TAK1/JNK signaling pathway.
Shen J; Fan Z; Sun G; Qi G
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34296299
[TBL] [Abstract][Full Text] [Related]
7. Phloretin ameliorates heart function after myocardial infarction via NLRP3/Caspase-1/IL-1β signaling.
Li B; Xu L; Liu J; Zhou M; Jiang X
Biomed Pharmacother; 2023 Sep; 165():115083. PubMed ID: 37413902
[TBL] [Abstract][Full Text] [Related]
8. CircHelz activates NLRP3 inflammasome to promote myocardial injury by sponging miR-133a-3p in mouse ischemic heart.
Bian Y; Pang P; Li X; Yu S; Wang X; Liu K; Ju J; Wu H; Gao Y; Liu Q; Jia Y; Qu Z; Bi X; Mei Z; Yin X; Wang N; Du W; Yang B
J Mol Cell Cardiol; 2021 Sep; 158():128-139. PubMed ID: 34043986
[TBL] [Abstract][Full Text] [Related]
9. The covalent NLRP3-inflammasome inhibitor Oridonin relieves myocardial infarction induced myocardial fibrosis and cardiac remodeling in mice.
Gao RF; Li X; Xiang HY; Yang H; Lv CY; Sun XL; Chen HZ; Gao Y; Yang JS; Luo W; Yang YQ; Tang YH
Int Immunopharmacol; 2021 Jan; 90():107133. PubMed ID: 33168408
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotective effect of cinnamaldehyde pretreatment on ischemia/ reperfusion injury via inhibiting NLRP3 inflammasome activation and gasdermin D mediated cardiomyocyte pyroptosis.
Luan F; Lei Z; Peng X; Chen L; Peng L; Liu Y; Rao Z; Yang R; Zeng N
Chem Biol Interact; 2022 Dec; 368():110245. PubMed ID: 36341777
[TBL] [Abstract][Full Text] [Related]
11. CLEC5A knockdown protects against cardiac dysfunction after myocardial infarction by suppressing macrophage polarization, NLRP3 inflammasome activation, and pyroptosis.
Wang X; Hu Y; Wang Y; Shen D; Tao G
Biochem Cell Biol; 2021 Oct; 99(5):655-665. PubMed ID: 33939927
[TBL] [Abstract][Full Text] [Related]
12. LuQi Formula Regulates NLRP3 Inflammasome to Relieve Myocardial-Infarction-Induced Cardiac Remodeling in Mice.
Zhang X; Zhao D; Feng J; Yang X; Lan Z; Yang T; Kong X; Qu H; Zhou H
Evid Based Complement Alternat Med; 2021; 2021():5518083. PubMed ID: 34257682
[TBL] [Abstract][Full Text] [Related]
13. NF-κB-Gasdermin D (GSDMD) Axis Couples Oxidative Stress and NACHT, LRR and PYD Domains-Containing Protein 3 (NLRP3) Inflammasome-Mediated Cardiomyocyte Pyroptosis Following Myocardial Infarction.
Lei Q; Yi T; Chen C
Med Sci Monit; 2018 Aug; 24():6044-6052. PubMed ID: 30161099
[TBL] [Abstract][Full Text] [Related]
14. Reducing myocardial infarction by combination of irisin and
Ding C; Zhang C
Chin J Physiol; 2023; 66(5):351-358. PubMed ID: 37929346
[TBL] [Abstract][Full Text] [Related]
15. Cardioprotective activity of ethyl acetate extract of Cinnamomi Ramulus against myocardial ischemia/reperfusion injury in rats via inhibiting NLRP3 inflammasome activation and pyroptosis.
Peng L; Lei Z; Rao Z; Yang R; Zheng L; Fan Y; Luan F; Zeng N
Phytomedicine; 2021 Dec; 93():153798. PubMed ID: 34673348
[TBL] [Abstract][Full Text] [Related]
16. Kanglexin, a novel anthraquinone compound, protects against myocardial ischemic injury in mice by suppressing NLRP3 and pyroptosis.
Bian Y; Li X; Pang P; Hu XL; Yu ST; Liu YN; Li X; Wang N; Wang JH; Xiao W; Du WJ; Yang BF
Acta Pharmacol Sin; 2020 Mar; 41(3):319-326. PubMed ID: 31645662
[TBL] [Abstract][Full Text] [Related]
17. [Knockout of PTEN improves cardiac function and inhibits NLRP3-mediated cardiomyocyte pyroptosis in rats with myocardial ischemia-reperfusion].
Cui Q; Wang J; Liu X; Wang X; Su G
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Mar; 36(3):205-211. PubMed ID: 32389167
[TBL] [Abstract][Full Text] [Related]
18. Astragaloside IV Inhibits NLRP3 Inflammasome-Mediated Pyroptosis via Activation of Nrf-2/HO-1 Signaling Pathway and Protects against Doxorubicin-Induced Cardiac Dysfunction.
Chen X; Tian C; Zhang Z; Qin Y; Meng R; Dai X; Zhong Y; Wei X; Zhang J; Shen C
Front Biosci (Landmark Ed); 2023 Mar; 28(3):45. PubMed ID: 37005753
[TBL] [Abstract][Full Text] [Related]
19. Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway.
Zhang J; Huang L; Shi X; Yang L; Hua F; Ma J; Zhu W; Liu X; Xuan R; Shen Y; Liu J; Lai X; Yu P
Aging (Albany NY); 2020 Nov; 12(23):24270-24287. PubMed ID: 33232283
[TBL] [Abstract][Full Text] [Related]
20. Deficiency of tenascin-C attenuated cardiac injury by inactivating TLR4/NLRP3/caspase-1 pathway after myocardial infarction.
Xu M; Ye Z; Zhao X; Guo H; Gong X; Huang R
Cell Signal; 2021 Oct; 86():110084. PubMed ID: 34271086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
